1-Z: Filer Information

Issuer CIK

0001133818

Issuer CCC

XXXXXXXX

File Number

Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?

Yes

Successor File Number

Is this a LIVE or TEST Filing?

LIVE

TEST

Is this an electronic copy of an official filing submitted in paper format?

Would you like a Return Copy?

Submission Contact Information

Name

Phone

E-Mail Address

Notify via Filing Website only?

1-Z: PRELIMINARY INFORMATION

Exact name of issuer as specified in the issuer's charter

Bio-Path Holdings, Inc.

Address of Principal Executive Offices

Address 1

625 Stanwix Street

Address 2

#2407

City

Pittsburgh

State/Country

PENNSYLVANIA

Mailing Zip/ Postal Code

15222

Phone

630-708-0750

Commission File Number(s)

024-12601

1-Z: PART I Summary Information Regarding the Offering and Proceeds

Summary Information

Date of qualification of the offering statement

05-29-2025

Date of commencement of the offering

05-30-2025

Amount of securities qualified to be sold in the offering

35714285

Amount of securities sold in the offering

Price per security:

$ 0.1400

The portion of aggregate sales attributable to securities sold on behalf of the issuer

$ 0.00

The portion of aggregate sales attributable to securities sold on behalf of selling securityholders:

$ 0.00

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider

D. Boral Capital

Underwriters - Fees

$ 0.00

Sales Commissions - Name of Service Provider

n/a

Sales Commissions - Fee

$ 0.00

Finders' Fees - Name of Service Provider

n/a

Finders' Fees - Fees

$ 0.00

Accounting or Audit - Name of Service Provider

Ernst & Young

Accounting or Audit - Fees

$ 0.00

Legal - Name of Service Provider

Winstead PC

Legal - Fees

$ 0.00

Promoters - Name of Service Provider

n/a

Promoters - Fees

$ 0.00

Blue Sky Compliance - Name of Service Provider

n/a

Blue Sky Compliance - Fees

$ 0.00

CRD Number of any broker or dealer listed

Net proceeds to the issuer

$ 0.00

Clarification of responses (if necessary):

No securities were sold in the Offering. Amount of securities qualified in the Offering is based on the post qualification Offering Circular supplement filed on June 2, 2025 under 253(g)(3).

1-Z: PART II Certification of Suspension of Duty to File Reports

Certification

Title of each class of securities covered by this Form

Common Stock

Commission File Number(s)

024-12601

Approximate number of holders of record as of the certification date

462

1-Z: Signature

Signature

Pursuant to the requirements of Regulation A,

Cik

0001133818

(Name of issuer as specified in charter)

BIO-PATH HOLDINGS, INC.

certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.

(Name of issuer as specified in charter)

BIO-PATH HOLDINGS, INC.

Has caused this certification to be signed on its behalf by the undersigned duly authorized person.

Vikram Grover

Date

02-25-2026

Title

CEO

Instructions: This Part II of Form 1-Z is required by Rule 257(d) of Regulation A. An officer of the issuer or any other duly authorized person may sign, and must do so by typed signature. The name and title of the person signing the form must be typed or printed under the signature. The signatory to the filing must also manually sign a signature page or other document authenticating, acknowledging or otherwise adopting his or her signature that appears in the filing. Such document must be executed before or at the time the filing is made and must be retained by the issuer for a period of five years. Upon request, the issuer must furnish to the Commission or its staff a copy of any or all documents retained pursuant to this instruction.

SEC Form 1-Z filed by Bio-Path Holdings Inc.